Dario Paggiarino

Dario Paggiarino

Plus aucun poste en cours

Fortune : 1 M $ au 31/03/2024

67 ans
Health Technology
Consumer Services

Profil

Dario A.
Paggiarino
is a former Executive Director-Clinical Development at Pfizer Inc. from 2001 to 2011.
He also worked as a Clinical Director at Pharmacia Corp.
and as an Executive Director-Clinical Development at Pfizer (St. Louis).
Additionally, he served as Vice President at Alcon Laboratories, Inc. Dr. Paggiarino was the Chief Development Officer & Senior Vice President at Lpath, Inc. from 2013 to 2016.
He also held the position of President at Angelini Pharmaceuticals Romania SRL.
Currently, he is the Chief Medical Officer & Senior Vice President at EyePoint Pharmaceuticals, Inc. starting from 2019.
Dr. Paggiarino obtained his doctorate degree from Sapienza University of Rome.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/03/2024 67 080 ( 0,13% ) 1 M $ 31/03/2024

Anciens postes connus de Dario Paggiarino

SociétésPosteFin
EYEPOINT PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 04/03/2024
Corporate Officer/Principal 22/07/2016
PFIZER, INC. Corporate Officer/Principal 01/01/2011
Corporate Officer/Principal -
President -
Voir l'expérience en détail de Dario Paggiarino

Formation de Dario Paggiarino

Sapienza University of Rome Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Dario Paggiarino

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
PFIZER, INC.

Health Technology

EYEPOINT PHARMACEUTICALS, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Dario Paggiarino